Niklas Feldhahn

6.4k total citations
41 papers, 2.1k citations indexed

About

Niklas Feldhahn is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Niklas Feldhahn has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 17 papers in Molecular Biology and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Niklas Feldhahn's work include Chronic Myeloid Leukemia Treatments (15 papers), Acute Lymphoblastic Leukemia research (14 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Niklas Feldhahn is often cited by papers focused on Chronic Myeloid Leukemia Treatments (15 papers), Acute Lymphoblastic Leukemia research (14 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Niklas Feldhahn collaborates with scholars based in United States, Germany and United Kingdom. Niklas Feldhahn's co-authors include Michel C. Nussenzweig, Davide F. Robbiani, André Nussenzweig, Anne Bothmer, Elsa Callén, Markus Müschen, Michela Di Virgilio, Anna Gazumyan, Hassan Jumaa and Mila Janković and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Niklas Feldhahn

40 papers receiving 2.0k citations

Peers

Countries citing papers authored by Niklas Feldhahn

Since Specialization

Citations

This map shows the geographic impact of Niklas Feldhahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niklas Feldhahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niklas Feldhahn more than expected).

Fields of papers citing papers by Niklas Feldhahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niklas Feldhahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niklas Feldhahn. The network helps show where Niklas Feldhahn may publish in the future.

Co-authorship network of co-authors of Niklas Feldhahn

This figure shows the co-authorship network connecting the top 25 collaborators of Niklas Feldhahn. A scholar is included among the top collaborators of Niklas Feldhahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niklas Feldhahn. Niklas Feldhahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Promoter‐centred chromatin interactions associated with EVI1 expression in EVI1 +3q− myeloid leukaemia cells 2024 ·British Journal of Haematology ·(unknown), Mark E. Robinson, Philippa C. May, Andrew J. Innes, (unknown), Niklas Feldhahn	0
2	Tissue-resident memory T cells in epicardial adipose tissue comprise transcriptionally distinct subsets that are modulated in atrial fibrillation 2024 ·Nature Cardiovascular Research ·Vishal Vyas, (unknown), (unknown), Elizabeth G. Wood, (unknown), Aled Jones, Eriomina Shahaj, (unknown), Jack Williams, (unknown), Mirjana Efremova, (unknown), (unknown), (unknown), Niklas Feldhahn, Federica M. Marelli‐Berg, Benny Chain, Andrew Tinker, Malcolm Finlay, M. Paula Longhi	12
3	MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis 2023 ·Blood Advances ·(unknown), (unknown), (unknown), Ioannis V. Kostopoulos, (unknown), (unknown), (unknown), Pierangela Sabbattini, Niklas Feldhahn, Maria Papaioannou, Evdoxia Hatjiharissi, Ian Sudbery, Aristeidis Chaidos, Valentina S. Caputo, Anastasios Karadimitris	3
4	Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres 2021 ·Nature Communications ·(unknown), Paulina Marzec, Aurora Idilli, Grzegorz Sarek, Aleksandra Vančevska, Mark Bower, Paul J. Farrell, Päivi M. Ojala, Niklas Feldhahn, Simon J. Boulton	18
5	The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation 2019 ·Oncogene ·Katarzyna Parzych, Paula Saavedra-García, Gabriel N. Valbuena, (unknown), Mark E. Robinson, (unknown), (unknown), (unknown), Sandra Loaiza, (unknown), Valentina S. Caputo, David C. Johnson, Martin Kaiser, Anastasios Karadimitris, Eric W.‐F. Lam, Éric Chevet, Niklas Feldhahn, Hector C. Keun, Holger W. Auner	33
6	Lineage-Specific Genes Are Prominent DNA Damage Hotspots during Leukemic Transformation of B Cell Precursors 2017 ·Cell Reports ·(unknown), Mark E. Robinson, Philippa C. May, Leandro Castellano, Kevin Blighe, (unknown), Alistair Reid, Markus Müschen, Jane F. Apperley, Justin Stebbing, Niklas Feldhahn	13
7	Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma 2015 ·Cell ·Davide F. Robbiani, Stephanie Deroubaix, Niklas Feldhahn, Thiago Y. Oliveira, Elsa Callén, Qiao Wang, Mila Janković, Israel Tojal da Silva, Philipp C. Rommel, David Bosque, (unknown), André Nussenzweig, Michel C. Nussenzweig	105
8	Rif1 Prevents Resection of DNA Breaks and Promotes Immunoglobulin Class Switching 2013 ·Science ·Michela Di Virgilio, Elsa Callén, Arito Yamane, Wenzhu Zhang, Mila Janković, Alexander D. Gitlin, Niklas Feldhahn, Wolfgang Resch, Thiago Y. Oliveira, Brian T. Chait, André Nussenzweig, Rafael Casellas, Davide F. Robbiani, Michel C. Nussenzweig	309
9	53BP1 Alters the Landscape of DNA Rearrangements and Suppresses AID-Induced B Cell Lymphoma 2013 ·Molecular Cell ·Mila Janković, Niklas Feldhahn, Thiago Y. Oliveira, Israel Tojal da Silva, Kyong-Rim Kieffer-Kwon, Arito Yamane, Wolfgang Resch, Isaac A. Klein, Davide F. Robbiani, Rafael Casellas, Michel C. Nussenzweig	31
10	Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemia 2012 ·OncoImmunology ·Niklas Feldhahn, Anna Arutyunyan, (unknown), Bin Zhang, Sabine Schmidhuber, Sun-Ju Yi, Yong‐Mi Kim, John Groffen, Nora Heisterkamp	17
11	Expression of cassini, a murine gamma-satellite sequence conserved in evolution, is regulated in normal and malignant hematopoietic cells 2012 ·BMC Genomics ·Anna Arutyunyan, (unknown), Sun-Ju Yi, Fei Fei, (unknown), (unknown), Niklas Feldhahn, John Groffen, Nora Heisterkamp	6
12	Regulation of DNA End Joining, Resection, and Immunoglobulin Class Switch Recombination by 53BP1 2011 ·Molecular Cell ·Anne Bothmer, Davide F. Robbiani, Michela Di Virgilio, Samuel F. Bunting, Isaac A. Klein, Niklas Feldhahn, Jacqueline H. Barlow, Hua-Tang Chen, David Bosque, Elsa Callén, André Nussenzweig, Michel C. Nussenzweig	186
13	AID Produces DNA Double-Strand Breaks in Non-Ig Genes and Mature B Cell Lymphomas with Reciprocal Chromosome Translocations 2009 ·Molecular Cell ·Davide F. Robbiani, Samuel F. Bunting, Niklas Feldhahn, Anne Bothmer, Jordi Camps, Stephanie Deroubaix, Kevin M. McBride, Isaac A. Klein, Gary Stone, Thomas Eisenreich, Thomas Ried, André Nussenzweig, Michel C. Nussenzweig	197
14	The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia 2009 ·Cancer Cell ·Lars Klemm, Cihangir Duy, Ilaria Iacobucci, Stefan Kuchen, Gregor von Levetzow, Niklas Feldhahn, Nadine Henke, (unknown), Thomas K. Hoffmann, Yong‐Mi Kim, Wolf‐Karsten Hofmann, Hassan Jumaa, John Groffen, Nora Heisterkamp, Giovanni Martinelli, Michael R. Lieber, Rafael Casellas, Markus Müschen	120
15	Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia 2007 ·Molecular Cancer ·(unknown), Niklas Feldhahn, Bin Zhang, Daniel Trageser, Markus Müschen, (unknown), John Groffen, Nora Heisterkamp	33
16	Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1–transformed acute lymphoblastic leukemia cells 2007 ·The Journal of Experimental Medicine ·Niklas Feldhahn, Nadine Henke, (unknown), Cihangir Duy, (unknown), Florian Klein, Gregor von Levetzow, Bernd Giebel, Aihong Li, Wolf‐Karsten Hofmann, Hassan Jumaa, Markus Müschen	70
17	Tracing the Pre-B to Immature B Cell Transition in Human Leukemia Cells Reveals a Coordinated Sequence of Primary and Secondary IGK Gene Rearrangement, IGK Deletion, and IGL Gene Rearrangement 2005 ·The Journal of Immunology ·Florian Klein, Niklas Feldhahn, Jana L. Mooster, Mieke Sprangers, Wolf‐Karsten Hofmann, Peter Wernet, Maria Wartenberg, Markus Müschen	34
18	BCR–ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells 2005 ·Oncogene ·Florian Klein, Niklas Feldhahn, Sebastian Herzog, Mieke Sprangers, Jana L. Mooster, Hassan Jumaa, Markus Müschen	44
19	The molecular requirements for LAT‐mediated differentiation and the role of LAT in limiting pre‐B cell expansion 2004 ·European Journal of Immunology ·Yuwen Su, Sebastian Herzog, Michael Lotz, Niklas Feldhahn, Markus Müschen, Hassan Jumaa	10
20	Tracing the pre-B to immature B cell transition in human leukemia cells reveals a coordinated sequence of primary and secondary IGK gene rearrangement, IGK deletion and IGL gene rearrangement 2004 ·Jana L. Mooster, Florian Klein, Niklas Feldhahn, Mieke Sprangers, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact